Key facts
- Riverfield’s last known valuation is $112.6M (Sep 2021).
- It has raised $43.1M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Mitsubishi UFJ Capital, SBI Investment, J-Startup, Beyond Next Ventures, Japan Post Capital — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Riverfield
- ·The full record, as it builds
Funding rounds
No funding rounds for Riverfield are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Riverfield
Developer of advanced medical robotics designed to enhance the precision and safety of minimally invasive surgeries. The company offers pneumatic control technology, ISO-certified safety design, and surgeon-centered product development, enabling healthcare professionals to perform delicate surgical procedures with greater accuracy, efficiency, and patient comfort.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2014
- Employees
- 62
- Website
- riverfieldinc.com/
- Ownership
- Privately Held (backing)
Riverfield doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Riverfield shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Riverfield in its N-PORT filings yet. We sweep new filings monthly.